Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-09-22 Purchase | 2023-09-25 5:03 pm | Aptose Biosciences Inc. | APTO | Seizinger Bernd R. Director | 17,000 | $3.14 | $53,380 | 17,000 (Direct) | View |
2022-09-19 Purchase | 2022-09-21 6:07 pm | Aptose Biosciences Inc. | APTO | Rice William G. Chair, President & CEO | 10,000 | $0.6834 | $6,834 | 363,252 (Direct) | View |
2022-09-19 Purchase | 2022-09-21 6:06 pm | Aptose Biosciences Inc. | APTO | Payne Fletcher SR VP & Chief Fin. Officer | 10,000 | $0.6775 | $6,775 | 10,000 (Indirect) | View |
2022-06-06 Purchase | 2022-06-06 4:13 pm | Aptose Biosciences Inc. | APTO | Rice William G. Chair, President & CEO | 10,000 | $0.9681 | $9,681 | 353,252 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-05 Option Award | 2024-02-07 6:06 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Payne Fletcher Sr VP and CFO | 55,000 | $0 | 55,000 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 5:45 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr VP & Chief Medical Officer | 35,000 | $0 | 35,000 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 5:26 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | LEDRU PHILIPPE Sr VP & Ch Commerical Officer | 11,000 | $0 | 11,000 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 5:15 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Rice William G. Chair, President & CEO | 70,000 | $0 | 70,000 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 4:56 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Seizinger Bernd R. Director | 3,333 | $0 | 3,333 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 4:52 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | PLATZER ERICH Director | 3,333 | $0 | 3,333 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 4:50 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Vincent Mark D. Director | 3,333 | $0 | 3,333 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 4:44 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Ashe Carol Gail Director | 3,333 | $0 | 3,333 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 4:39 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | BURGER DENIS R Director | 3,333 | $0 | 3,333 (Direct) | View |
2024-02-05 Option Award | 2024-02-07 4:33 pm | N/A 2034-02-05 | Aptose Biosciences Inc. | APTO | Whitehead Warren Director | 3,333 | $0 | 3,333 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 8:08 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | Whitehead Warren Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 8:04 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | Vincent Mark D. Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 8:03 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | Seizinger Bernd R. Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 8:00 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | Rice William G. Chair, President & CEO | 550,000 | $0 | 913,252 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 7:58 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | PLATZER ERICH Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 7:57 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | Payne Fletcher SR VP & Chief Fin. Officer | 300,000 | $0 | 310,000 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 7:55 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | LEDRU PHILIPPE Chief Commercial Officer | 300,000 | $0 | 300,500 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 7:53 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | BURGER DENIS R Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 7:51 pm | N/A 2033-11-19 | Aptose Biosciences Inc. | APTO | Ashe Carol Gail Director | 100,000 | $0 | 100,000 (Direct) | View |
2023-01-19 Option Award | 2023-01-23 7:50 pm | N/A 2033-01-19 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 300,000 | $0 | 310,000 (Direct) | View |
2022-09-14 Option Award | 2022-09-16 5:32 pm | N/A 2032-09-14 | Aptose Biosciences Inc. | APTO | Seizinger Bernd R. Director | 50,000 | $0 | 50,000 (Direct) | View |
2022-07-06 Option Award | 2022-07-07 6:39 pm | N/A 2032-07-06 | Aptose Biosciences Inc. | APTO | Rice William G. Chair, President & CEO | 600,000 | $0 | 600,000 (Direct) | View |
2022-06-27 Option Award | 2022-06-28 4:16 pm | N/A 2032-06-26 | Aptose Biosciences Inc. | APTO | Payne Fletcher SR VP & Chief Fin. Officer | 1,000,000 | $0 | 1,000,000 (Direct) | View |
2022-04-13 Option Award | 2022-04-14 8:59 pm | N/A 2032-04-12 | Aptose Biosciences Inc. | APTO | LEDRU PHILIPPE Chief Commercial Officer | 600,000 | $0 | 600,000 (Direct) | View |
Ownership | 2022-04-14 8:58 pm | N/A N/A | Aptose Biosciences Inc. | APTO | LEDRU PHILIPPE Chief Commercial Officer | 0 | $0 | 500 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 6:04 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | Ashe Carol Gail Director | 50,000 | $0 | 50,000 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 5:18 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | Rice William G. Chair, President & CEO | 700,000 | $0 | 700,000 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 5:17 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | Marango Jotin Senior VP, CFO, and CBO | 600,000 | $0 | 600,000 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 5:16 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | Bejar Rafael Sr. VP, Chief Medical Officer | 600,000 | $0 | 600,000 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 5:15 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | Vincent Mark D. Director | 50,000 | $0 | 50,000 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 5:14 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | BURGER DENIS R Director | 50,000 | $0 | 50,000 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 5:13 pm | N/A 2032-01-17 | Aptose Biosciences Inc. | APTO | Loewy Caroline M Director | 50,000 | $0 | 50,000 (Direct) | View |